Women With Lifelong Irregular or Long Menstrual Cycles at Higher Risk for T2D
Is the regularity of a woman’s menstrual cycles during her reproductive life a significant and independent predictor for T2D risk?
Contraception
Lasting Protection Against Ovarian, Endometrial Cancer With OCPs
Increased risk for breast cancer observed, which was seen for up to two years after discontinuation of oral contraceptives
Twirla Transdermal System Now Available for Contraception
Twirla (levonorgestrel and ethinyl estradiol) transdermal system is now available as a method of contraception for use in women of reproductive potential with a BMI <30kg/m2 for whom a combined hormonal contraceptive is appropriate.
FDA Approves Generic Version of Oral Contraceptive Taytulla
Gemmily contains 24 active capsules containing 1mg of norethindrone acetate and 20mcg of ethinyl estradiol and 4 capsules containing 75mg of ferrous fumarate (nonhormonal placebo).
The Art of Managing Long Acting Reversible Contraception for Adolescent Patients
Long-acting reversible contraception, such as hormonal and non-hormonal intrauterine devices (IUDs) and hormonal implants, have been proven safe and effective for adolescent patients.
COVID-19 May Increase VTE Risk in Pregnant Women, Individuals Taking Estrogen Therapy
Several questions remain regarding the effect of COVID-19 infection and hypercoagulation in the management of patients taking oral contraceptives, estrogen therapy, and patients who are pregnant.
Higher Rates of Pain, Bleeding Found With Essure Birth Control Device
The permanent birth control device Essure is associated with higher rates of chronic lower abdominal or pelvic pain and abnormal uterine bleeding compared with tubal ligation.
Employers Can Refuse to Provide Birth Control Coverage, Rules US Supreme Court
More than 70,000 US women could be left without cost-free birth control after the Supreme Court upheld a Trump administration policy change that permits some employers to refuse to provide contraceptive coverage on religious or moral grounds.
Contraceptives Beneficial for Premature Ovarian Insufficiency
For women with premature ovarian insufficiency, continuous use of combined oral contraceptives is associated with increased BMD, similar to that seen with high-dose hormone therapy.
Oral Contraceptive With Novel Estrogen Under FDA Review
The novel combined oral contraceptive pill includes estetrol 15mg (E4) and drospirenone 3mg (DRSP).
-
Loading...
-
Loading...
Next post in General Endocrinology
